Table 3.
Median Glucose Concentration, Glycemic Variability, and Time in Target Range in Patients Without a Diagnosis of Diabetes Mellitus (ND) and Patients With Type 2 Diabetes Mellitus (T2DM) During Period 1 (GM1) Compared to Period 2 (GM2).
| ND |
T2DM |
|||||
|---|---|---|---|---|---|---|
| Period 1 | Period 2 | P value | Period 1 | Period 2 | P value | |
| Number of patients | 35 | 35 | N/A | 35 | 35 | N/A |
| Glucose concentration (mg/dL), median (IQR) | 134 (122, 149) | 133 (121, 145) | .06 | 146 (132, 162) | 139 (128, 153) | .02 |
| Glucose SD (mg/dL), median (IQR) | 18.7 (16.3, 25.6) | 15.4 (12.4, 19.9) | .004 | 22.4 (17.7, 28.0) | 13.6 (12.3, 18.3) | <.0001 |
| Glucose CONGA (mg/dL), median (IQR) | 18.3 (13.3, 21.6) | 13.5 (10.2, 19.0) | .04 | 21.4 (18.3, 27.5) | 13.5 (11.7, 15.2) | <.0001 |
| Percentage glucose values in target range (%), median (IQR) | 68.8 (61.9, 79.2) | 73.7 (62.5, 87.5) | .10 | 61.9 (46.7, 72.7) | 78.3 (54.2, 85.7) | .006 |
CONGA, continuous overall net glycemic action; IQR, interquartile range; N/A, not applicable; SD, standard deviation. To convert mg/dL to mmol/L, multiply by 0.0555.